Evidence map›Paper›PMID 27896578›Full record

ArticleInternational urology and nephrology2017

Is there evidence for a close connection between side of intravesical tumor location and ipsilateral lymphatic spread in lymph node-positive bladder cancer patients at radical cystectomy? Results of the PROMETRICS 2011 database.

M May, C Protzel, M W Vetterlein, M Gierth, J Noldus, A Karl, T Grimm, B Wullich, M O Grimm, P Nuhn and 10 more

Abstract read
PubMed Publisher
In one paragraph

Article in International urology and nephrology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

M MayDepartment of Urology, St. Elisabeth-Hospital Straubing, St. Elisabeth-Straße 23, 94315, Straubing, Germany. matthias.may@klinikum-straubing.de.
C ProtzelDepartment of Urology, University of Rostock, Rostock, Germany.
M W VetterleinDepartment of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
M GierthDepartment of Urology, Caritas-Hospital St. Josef, University of Regensburg, Regensburg, Germany.
J NoldusDepartment of Urology, Ruhr-University of Bochum, Marien-Hospital Herne, Herne, Germany.
A KarlDepartment of Urology, Ludwig-Maximilians-University Munich, Munich, Germany.
T GrimmDepartment of Urology, Ludwig-Maximilians-University Munich, Munich, Germany.
B WullichDepartment of Urology, University of Erlangen, Erlangen, Germany.
M O GrimmDepartment of Urology, University of Jena, Jena, Germany.
P NuhnDepartment of Urology, University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany.
P J BastianDepartment of Urology, Marien-Hospital Düsseldorf, Düsseldorf, Germany.
J RoigasDepartment of Urology, Vivantes-Clinic Am Friedrichshain, Berlin, Germany.
B HadaschikDepartment of Urology, University of Heidelberg, Heidelberg, Germany.
C GilfrichDepartment of Urology, St. Elisabeth-Hospital Straubing, St. Elisabeth-Straße 23, 94315, Straubing, Germany.
M BurgerDepartment of Urology, Caritas-Hospital St. Josef, University of Regensburg, Regensburg, Germany.
M FischDepartment of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
S Brookman-MayDepartment of Urology, Ludwig-Maximilians-University Munich, Munich, Germany.
A AzizDepartment of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
O W HakenbergDepartment of Urology, University of Rostock, Rostock, Germany.
PROMETRICS 2011 Research Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo evaluate the possible association between bladder tumor location and the laterality of positive lymph nodes (LN) in a prospectively collected multi-institutional radical cystectomy (RC) series.

methodsThe study population included 148 node-positive bladder cancer (BC) patients undergoing RC and pelvic lymph node dissection in 2011 without neoadjuvant chemotherapy and without distant metastasis. Tumor location was classified as right, left or bilateral and compared to the laterality of positive pelvic LN. A logistic regression model was used to identify predictors of ipsilaterality of lymphatic spread. Using multivariate Cox regression analyses (median follow-up: 25 months), the effect of the laterality of positive LN on cancer-specific mortality (CSM) was estimated.

resultsOverall, median 18.5 LN [interquartile range (IQR), 11-27] were removed and 3 LN (IQR 1-5) were positive. There was concordance of tumor location and laterality of positive LN in 82% [95% confidence interval (CI), 76-89]. Patients with unilateral tumors (n = 78) harbored exclusively ipsilateral positive LN in 67% (95% CI 56-77). No criteria were found to predict ipsilateral positive LN in patients with unilateral tumors. CSM after 3 years in patients with ipsilateral, contralateral, and bilateral LN metastasis was 41, 67, and 100%, respectively (p = 0.042). However, no significant effect of the laterality of positive pelvic LN on CSM could be confirmed in multivariate analyses.

conclusionsOur prospective cohort showed a concordance of tumor location and laterality of LN metastasis in BC at RC without any predictive criteria and without any influence on CSM. It is debatable, whether these findings may contribute to a more individualized patient management.

Indexed as

Carcinoma, Transitional CellCystectomyUrinary BladderUrinary Bladder NeoplasmsAdultAgedDatabases, FactualFemaleGermanyHumansLymphatic MetastasisLymphatic VesselsLymph Node ExcisionMaleMiddle AgedMultivariate AnalysisCystectomyLaterality of lymph node metastasisLymph node dissectionTumor locationUrinary bladder neoplasms

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.